A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with ...
ABSTRACT: Acute Lymphoblastic Leukemia (ALL), a highly aggressive subtype of blood cancer, demands early and accurate diagnosis to improve patient outcomes. Traditional diagnostic methods relying on ...
ABSTRACT: Acute Lymphoblastic Leukemia (ALL), a highly aggressive subtype of blood cancer, demands early and accurate diagnosis to improve patient outcomes. Traditional diagnostic methods relying on ...
Many people think of leukemia as a childhood cancer—and while it is the most common type in children under 15, it actually occurs most often in adults older than 55, per the National Cancer Institute.
Abstract: All Acute Lymphoblastic Leukemia (ALL) is a hematological malignant disease that develops at a rapid pace and is mostly common with children and young adults, in both cases diagnosis is ...
Abstract: Acute Lymphoblastic Leukemia (ALL) is an aggressive blood cancer affecting immature lymphocytes, requiring timely and accurate diagnosis. Traditional methods are slow, expertise-dependent, ...
This multivariate analysis also suggested the presence of previously unrecognized subclusters within the favorable prognosis category, indicating the potential for finer risk stratification. Raman ...
Central nervous system (CNS) relapse in acute myeloid leukemia (AML) is an uncommon but clinically significant event, with isolated CNS involvement occurring in a minority of cases and often eluding ...
Leukemia, a heterogeneous group of hematological malignancies, is characterized by abnormal proliferation of immature hematopoietic cells. Current diagnostics primarily rely on morphological ...
BOSTON, September 22, 2025 — Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified and treated. The tool ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results